Effective half-life in clinical pharmacology.
Boxenbaum
H
H
Wyeth-Ayerst Research, Philadelphia, Pennsylvania 19101, USA.
Battle
M
M
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D008954:Models, Biological; D009281:Naphthalenes / Q000493:pharmacokinetics; D010601:Pharmacology, Clinical; D013467:Sulindac / Q000493:pharmacokinetics; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D009281:Naphthalenes; C040550:tolrestat; D013467:Sulindac; D000449:Aldehyde Reductase